The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats

European Neuropsychopharmacology

Volumn 20, Issue 6, 2010, Pages 421-425

  Weber, Martin ^a   Chang, Wei Li ^a   Breier, Michelle R ^a   Yang, Alex ^a   Millan, Mark J ^b   Swerdlow, Neal R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

D2 receptor; Dopamine; Prepulse inhibition; Schizophrenia; Sumanirole

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; SUMANIROLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG MECHANISM; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; BENZIMIDAZOLES; DISCRIMINATION (PSYCHOLOGY); DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHERMIA; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STARTLE REACTION;

EID: 77952545638     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.02.011     Document Type: Article

References (20)

1. Achat-Mendes C., Platt D.M., Newman A.H., Spealman R.D. The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys. Psychopharmacology 2009, 206:73-84.
2. Chang W.L., Saint Marie R.L., Miller E., Weber M., Swerdlow N.R. Effects of the D3/D2 agonist, pramipexole, on sensorimotor gating and nucleus accumbens signaling in the rat. Biol. Psychiatry 2009, 65:76s.
3. Collins G.T., Newman A.H., Grundt P., Rice K.C., Husbands S.M., Chauvignac C., Chen J., Wang S., Woods J.H. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology 2007, 193:159-170.
4. Cussac D., Newman-Tancredi A., Sezgin L., Millan M.J. The novel antagonist, S33084, and GR218, 231 interact selectively with cloned and native, rat dopamine D(3) receptors as compared with native, rat dopamine D(2) receptors. Eur. J. Pharmacol. 2000, 394:47-50.
5. de Paulis T. Sumanirole Pharmacia. Curr. Opin. Investig. Drugs 2003, 4:77-82.
6. Heier R.F., Dolak L.A., Duncan J.N., Hyslop D.K., Lipton M.F., Martin I.J., Mauragis M.A., Piercey M.F., Nichols N.F., Schreur P.J., Smith M.W., Moon M.W. Synthesis and biological activities of (R)-5, 6-dihydro-N, N-dimethyl-4H-imidazo[4, 5, 1-ij]quinolin-5-amine and its metabolites. J. Med. Chem. 1997, 40:639-646.
7. Koffarnus M.N., Greedy B., Husbands S.M., Grundt P., Newman A.H., Woods J.H. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats. Psychopharmacology 2008, 203:317-327.
8. McCall R.B., Lookingland K.J., Bedard P.J., Huff R.M. Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease. J. Pharmacol. Exp. Ther. 2005, 314:1248-1256.
9. Millan M.J., Gobert A., Newman-Tancredi A., Lejeune F., Cussac D., Rivet J.M., Audinot V., Dubuffet T., Lavielle G. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218, 231 and L741, 626. J. Pharmacol. Exp. Ther. 2000, 293:1048-1062.
10. Millan M.J., Maiofiss L., Cussac D., Audinot V., Boutin J.A., Newman-Tancredi A. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J. Pharmacol. Exp. Ther. 2002, 303:791-804.
11. Millan M.J., Seguin L., Gobert A., Cussac D., Brocco M. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats. Psychopharmacology 2004, 174:341-357.
12. Saint Marie R.L., Neary A.C., Shoemaker J., Swerdlow N.R. Apomorphine effects on CREB phosphorylation in the nucleus accumbens of rat strains that differ in PPI sensitivity. Biol. Psychiatry 2007, 61:37s.
13. Swerdlow N.R., Shoemaker J.M., Auerbach P.P., Pitcher L., Goins J., Platten A. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology 2004, 174:452-462.
14. Swerdlow N.R., Weber M., Qu Y., Light G.A., Braff D.L. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology 2008, 199:331-388.
15. Swerdlow N.R., Lelham S.A., Sutherland Owens A.N., Chang W.L., Sassen S.D., Talledo J.A. Pramipexole effects on startle gating in rats and normal men. Psychopharmacology 2009, 205:689-698.
16. Wadenberg M.G., Sills T.L., Fletcher P.J., Kapur S. Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats. Biol. Psychiatry 2000, 47:670-676.
17. Weber M., Chang W.L., Breier M., Ko D., Swerdlow N.R. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation. Behav. Pharmacol. 2008, 19:786-795.
18. Weber M., Chang W.L., Durbin J.P., Park P.E., Luedtke R.R., Mach R.H., Swerdlow N.R. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44. Pharmacol. Biochem. Behav. 2009, 93:141-147.
19. Wuts P.G.M., Gu R.L., Northuis J.M., Kwan T.A., Beck D.M., White M.J. Development of a practical synthesis of sumanirole. Pure Appl. Chem. 2002, 74:1359-1368.
20. Zhang M., Ballard M.E., Unger L.V., Haupt A., Gross G., Decker M.W., Drescher K.U., Rueter L.E. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine. Behav. Brain Res. 2007, 182:1-11.